An article by Campbell et al. (2024) provides some guidance. The authors developed a set of recommendations based on a literature review, expert interviews, and an expert workshop to support the consistent and transparent assessment and use of validated family spillovers in health technology assessments (HTAs) and cost-effectiveness analyses (CEAs). The expert panel consisted of 2 patient advocates, 2 health economists, 2 outcomes researchers, 1 health policy expert, and 1 payer.
Based on this approach, the experts developed 15 recommendations with a medium to high level of consensus. The recommendations were formulated for three different stakeholder groups: (i) health technology assessment agencies, (ii) researchers developing models, and (iii) researchers collecting and analysing data on indirect effects on families. These recommendations are listed in the table below.
For more context on these recommendations, please read the full article. here.
